<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">11815</article-id><article-id pub-id-type="doi">10.7554/eLife.11815</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Biophysics and Structural Biology</subject></subj-group></article-categories><title-group><article-title>Unnatural amino acid photo-crosslinking of the <italic>I<sub>Ks</sub></italic> channel complex demonstrates a KCNE1:KCNQ1 stoichiometry of up to 4:4</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-42778"><name><surname>Murray</surname><given-names>Christopher I</given-names></name><aff><institution content-type="dept">Department of Anesthesiology, Pharmacology and Therapeutics</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-43319"><name><surname>Westhoff</surname><given-names>Maartje</given-names></name><aff><institution content-type="dept">Department of Anesthesiology, Pharmacology and Therapeutics</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42924"><name><surname>Eldstrom</surname><given-names>Jodene</given-names></name><aff><institution content-type="dept">Department of Anesthesiology, Pharmacology and Therapeutics</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42922"><name><surname>Thompson</surname><given-names>Emely</given-names></name><aff><institution content-type="dept">Department of Anesthesiology, Pharmacology and Therapeutics</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42923"><name><surname>Emes</surname><given-names>Robert</given-names></name><aff><institution content-type="dept">Department of Anesthesiology, Pharmacology and Therapeutics</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-42920"><name><surname>Fedida</surname><given-names>David</given-names></name><aff><institution content-type="dept">Department of Anesthesiology, Pharmacology and Therapeutics</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country><email>david.fedida@ubc.ca</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1036"><name><surname>Aldrich</surname><given-names>Richard</given-names></name><role>Reviewing editor</role><aff><institution>The University of Texas at Austin</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>01</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e11815</elocation-id><supplementary-material><ext-link xlink:href="elife-11815-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>24</day><month>09</month><year>2015</year></date><date date-type="accepted"><day>22</day><month>01</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Murray et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Murray et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Cardiac repolarization is determined in part by the slow delayed rectifier current (<italic>I<sub>Ks</sub></italic>), through the tetrameric voltage-gated ion channel, KCNQ1, and its β-subunit, KCNE1. The stoichiometry between α and β-subunits has been controversial with studies reporting either a strict 2 KCNE1:4 KCNQ1 or a variable ratio up to 4:4. We used <italic>I<sub>Ks</sub></italic> fusion proteins linking KCNE1 to one (EQ), two (EQQ) or four (EQQQQ) KCNQ1 subunits, to reproduce compulsory 4:4, 2:4 or 1:4 stoichiometries. Whole cell and single-channel recordings showed EQQ and EQQQQ to have increasingly hyperpolarized activation, reduced conductance, and shorter first latency of opening compared to EQ - all abolished by the addition of KCNE1. As well, using a UV-crosslinking unnatural amino acid in KCNE1, we found EQQQQ and EQQ crosslinking rates to be progressively slowed compared to KCNQ1, which demonstrates that no intrinsic mechanism limits the association of up to four β-subunits within the <italic>I<sub>Ks</sub></italic> complex.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>